HEART FAILURE IN 2015: Better results from prevention than from additional treatment

    loading  Checking for direct PDF access through Ovid

Abstract

In 2015, success in clinical trials in heart failure was obtained mainly from prevention, whereas treatments showed neutral or even adverse effects. A new glucose-lowering medication prevents development of heart failure. Treating central sleep apnoea might be harmful. In Chagas cardiomyopathy, benznidazole treatment did not affect long-term clinical outcomes.

Related Topics

    loading  Loading Related Articles